President and CEO

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Rigel Pharmaceuticals: First patient enrolled in Phase 1b study of R289

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals announces inducement grants

Executive Director, Account Management

Rigel Pharmaceuticals Inc. is a leading company in the pharmaceutical industry, and they are seeking an Executive Director of Payer & Account Management. This role involves overseeing market access account strategies, building relationships with key stakeholders, and leading a field account team to ensure product access and reimbursement.

Senior Vice President Human Resources

Staffing Consultant

National Account Director

Territory Business Manager

Sign up with Google

Sign in with Google